A deep learning framework for drug repurposing via emulating clinical trials on real-world patient data.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 35603127.
- Also identified by DOI 10.1038/s42256-020-00276-w and PMC identifier 9119409.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Drug repurposing is an effective strategy to identify new uses for existing drugs, providing the quickest possible transition from bench to bedside. Real-world data, such as electronic health records and insurance claims, provide information on large cohorts of users for many drugs. Here we present an efficient and easily customized framework for generating and testing multiple candidates for drug repurposing using a retrospective analysis of real-world data. Building upon well-established causal inference and deep learning methods, our framework emulates randomized clinical trials for drugs present in a large-scale medical claims database. We demonstrate our framework on a coronary artery disease cohort of millions of patients. We successfully identify drugs and drug combinations that substantially improve the coronary artery disease outcomes but haven't been indicated for treating coronary artery disease, paving the way for drug repurposing.